COL18A1 and neoplasm: Talc-treated pleural mesothelium counteracts these effects by releasing endostatin, an anti-angiogenic factor which may be responsible for tumor containment within the pleural space and accounts for the improved clinical outcome of patients with malignant pleural effusions successfully pleurodesis with talc [24].